Product NDC: | 49884-659 |
Proprietary Name: | Candesartan cilexetil |
Non Proprietary Name: | Candesartan cilexetil |
Active Ingredient(s): | 8 mg/1 & nbsp; Candesartan cilexetil |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49884-659 |
Labeler Name: | Par Pharmaceutical Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020838 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20130521 |
Package NDC: | 49884-659-09 |
Package Description: | 90 TABLET in 1 BOTTLE (49884-659-09) |
NDC Code | 49884-659-09 |
Proprietary Name | Candesartan cilexetil |
Package Description | 90 TABLET in 1 BOTTLE (49884-659-09) |
Product NDC | 49884-659 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Candesartan cilexetil |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20130521 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Par Pharmaceutical Inc. |
Substance Name | CANDESARTAN CILEXETIL |
Strength Number | 8 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |